Cargando…

Quality of life of older gynecologic oncology patients at the initiation of chemotherapy

AIM: To evaluate older gynecologic oncology patients' quality of life (QOL) at the initiation of chemotherapy and compare their QOL scores with a female age‐matched general population (GP) sample. DESIGN: Cross‐sectional. METHODS: Older (n = 122) gynecologic oncology patients completed the Euro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleven, Anne Grethe, Miaskowski, Christine, Torstveit, Ann Helen, Ritchie, Christine Seel, Engh, Marie Ellström, Andersen, Elin, Utne, Inger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495706/
https://www.ncbi.nlm.nih.gov/pubmed/37337353
http://dx.doi.org/10.1002/nop2.1921
Descripción
Sumario:AIM: To evaluate older gynecologic oncology patients' quality of life (QOL) at the initiation of chemotherapy and compare their QOL scores with a female age‐matched general population (GP) sample. DESIGN: Cross‐sectional. METHODS: Older (n = 122) gynecologic oncology patients completed the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ‐C30) that evaluates global health and five functional scales (range from 0 to 100). Differences in QOL scores between our sample and the GP were evaluated using one‐sample t‐tests and effect sizes were calculated using Cohen's d. RESULTS: Patients' mean age was 70.7 years (±6.6). Mean scores for the function scales ranged from 58.5 (±31.1) for role function to 86.1 (±17.0) for cognitive function. Compared to the GP, our sample reported significantly lower scores for global health status, social, role and physical functioning, and a significantly higher score for cognitive functioning. No differences were found in emotional functioning scores. PATIENT OR PUBLIC CONTRIBUTION: No patient or public contribution.